Skip to content

Novel dual antibody therapy partially controls virulent HIV infection in monkeys off treatment

Zachary Strongin presenting to IAS 2021.

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir

Dr Brian Moldt presenting to IAS 2021.

HIV is associated with accelerated ageing that antiretroviral therapy only partially reverses

Image by UNAMID. Creative Commons licence.

São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatment

Dr Ricardo Diaz presenting to CROI 2021.

mRNA vaccine protects monkeys against HIV-like virus

Slide from Dr Peng Zhang's presentation to CROI 2021.

Therapeutic vaccine shows potential for HIV control off treatment in early study

Dr Beatriz Mothe (bottom left) presenting to CROI 2021.

Argentinian woman has been off HIV treatment for 12 years

Buenos Aires, Argentina. Andrea Leopardi/Unsplash

Where next for HIV vaccines and antibody therapies?

Dr Mark Feinberg, President of IAVI

The Buenos Aires patient: Argentinian woman controls HIV for at least 12 years after stopping treatment

Buenos Aires, Argentina. Andrea Leopardi/Unsplash